Tortolero-Luna G - Search Results

1

Mentorship and productivity among gynecologic oncology fellows.

Ramondetta LM, Bodurka DC, Tortolero-Luna G, Gordinier M, Wolf JK, Gershenson DM, Sciscione AC. Ramondetta LM, et al. J Cancer Educ. 2003 Spring;18(1):15-9. doi: 10.1207/s15430154jce1801_9. J Cancer Educ. 2003. PMID: 12825629

2

Prognostic significance of p53 expression in advanced-stage ovarian serous borderline tumors.

Gershenson DM, Deavers M, Diaz S, Tortolero-Luna G, Miller BE, Bast RC Jr, Mills GB, Silva EG. Gershenson DM, et al. Clin Cancer Res. 1999 Dec;5(12):4053-8. Clin Cancer Res. 1999. PMID: 10632339

3

Approaches for end-of-life care in the field of gynecologic oncology: an exploratory study.

Ramondetta LM, Tortolero-Luna G, Bodurka DC, Sills D, Basen-Engquist K, Gano J, Levenback C. Ramondetta LM, et al. Int J Gynecol Cancer. 2004 Jul-Aug;14(4):580-8. doi: 10.1111/j.1048-891X.2004.14402.x. Int J Gynecol Cancer. 2004. PMID: 15304150

4

Ovarian and extraovarian endometriosis-associated cancer.

Modesitt SC, Tortolero-Luna G, Robinson JB, Gershenson DM, Wolf JK. Modesitt SC, et al. Obstet Gynecol. 2002 Oct;100(4):788-95. doi: 10.1016/s0029-7844(02)02149-x. Obstet Gynecol. 2002. PMID: 12383550

5

Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk.

Oh JC, Wu W, Tortolero-Luna G, Broaddus R, Gershenson DM, Burke TW, Schmandt R, Lu KH. Oh JC, et al. Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):748-52. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15159305

6

Association between adiponectin, insulin resistance, and endometrial cancer.

Soliman PT, Wu D, Tortolero-Luna G, Schmeler KM, Slomovitz BM, Bray MS, Gershenson DM, Lu KH. Soliman PT, et al. Cancer. 2006 Jun 1;106(11):2376-81. doi: 10.1002/cncr.21866. Cancer. 2006. PMID: 16639730 Free article.

7

Serous borderline tumors of the ovary with noninvasive peritoneal implants.

Gershenson DM, Silva EG, Tortolero-Luna G, Levenback C, Morris M, Tornos C. Gershenson DM, et al. Cancer. 1998 Nov 15;83(10):2157-63. doi: 10.1002/(sici)1097-0142(19981115)83:10<2157::aid-cncr14>3.0.co;2-d. Cancer. 1998. PMID: 9827720

8

Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.

Ramirez PT, Gershenson DM, Tortolero-Luna G, Ramondetta LM, Fightmaster D, Wharton JT, Wolf JK. Ramirez PT, et al. Gynecol Oncol. 2001 Dec;83(3):543-8. doi: 10.1006/gyno.2001.6438. Gynecol Oncol. 2001. PMID: 11733969

9

Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential: a study of 99 advanced stage cases.

Deavers MT, Gershenson DM, Tortolero-Luna G, Malpica A, Lu KH, Silva EG. Deavers MT, et al. Am J Surg Pathol. 2002 Sep;26(9):1129-41. doi: 10.1097/00000478-200209000-00003. Am J Surg Pathol. 2002. PMID: 12218569

10

Innovations in understanding the biology of cervical cancer.

Wolf JK, Franco EL, Arbeit JM, Shroyer KR, Wu TC, Runowicz CD, Tortolero-Luna G, Herrero R, Crum CP. Wolf JK, et al. Cancer. 2003 Nov 1;98(9 Suppl):2064-9. doi: 10.1002/cncr.11682. Cancer. 2003. PMID: 14603543 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters